Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Tc Biopharm [Holdings] Plc WT (TCBPW)

Tc Biopharm [Holdings] Plc WT (TCBPW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ -7,350 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade TCBPW with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 05/06/24
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0200 +4.50%
on 04/23/24
0.0400 -47.75%
on 04/04/24
-0.0091 (-30.33%)
since 03/22/24
3-Month
0.0071 +194.37%
on 02/08/24
0.0500 -58.20%
on 03/13/24
+0.0029 (+16.11%)
since 01/23/24
52-Week
0.0019 +1,000.00%
on 10/25/23
0.1199 -82.57%
on 04/27/23
-0.1070 (-83.66%)
since 04/21/23

Most Recent Stories

More News
TC BioPharm Announces New Chair of the Board, Arlene Morris

/PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing...

TCBP : 1.5000 (-5.06%)
TCBPW : 0.0209 (-22.59%)
TC BioPharm to Reschedule Shareholder Update Call and Webcast

/PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing...

TCBP : 1.5000 (-5.06%)
TCBPW : 0.0209 (-22.59%)
TC BioPharm Announces Hiring of Chief Clinical Officer Bree Harlin to Lead Global Clinical Division

/PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing...

TCBP : 1.5000 (-5.06%)
TCBPW : 0.0209 (-22.59%)
TC BioPharm to Host Shareholder Update Call

/PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing...

TCBP : 1.5000 (-5.06%)
TCBPW : 0.0209 (-22.59%)
Initiatives For Development of Gamma Delta T Cell Therapies Driven by Large Number of Clinical Trials

EQNX::TICKER_START (NASDAQ:TCBP),(NASDAQ:CRDF),(NASDAQ:CYAD),(NASDAQ:RIGL),(NASDAQ:AZN) EQNX::TICKER_END

TCBP : 1.5000 (-5.06%)
TCBPW : 0.0209 (-22.59%)
CRDF : 4.19 (+0.48%)
CYAD : 0.4700 (-11.10%)
RIGL : 1.1150 (-2.19%)
AZN : 71.13 (+0.40%)
TC BioPharm Announces Strategic Collaboration to Advance Gamma Delta T Cells in Oncology

EQNX::TICKER_START (NASDAQ:TCBP) EQNX::TICKER_END

TCBP : 1.5000 (-5.06%)
TCBPW : 0.0209 (-22.59%)
TC BioPharm Announces Strategic Collaboration to Advance Gamma Delta T Cells in Oncology

/PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing...

TCBP : 1.5000 (-5.06%)
TCBPW : 0.0209 (-22.59%)
TC BioPharm Announces Closing of $7.35 Million Private Placement

/PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (Nasdaq: TCBP) (Nasdaq: TCBPW), a clinical stage biotechnology company developing...

TCBP : 1.5000 (-5.06%)
TCBPW : 0.0209 (-22.59%)
TC BioPharm Begins Dosing Phase 2B Clinical Study Evaluating its Lead Compound, OmnImmune®, in Patients with Acute Myeloid Leukemia

/PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing...

TCBP : 1.5000 (-5.06%)
TCBPW : 0.0209 (-22.59%)
TC BioPharm to Present at Upcoming Investor Conferences

/PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing...

TCBP : 1.5000 (-5.06%)
TCBPW : 0.0209 (-22.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar